Article Versions Notes

Stegel V, Blatnik A, Škof E, Dragoš VŠ, Krajc M, Gregorič B, Škerl P, Strojnik K, Klančar G, Banjac M, et al. Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing. Cancers. 2022; 14(6):1434. https://doi.org/10.3390/cancers14061434

Stegel, Vida, Ana Blatnik, Erik Škof, Vita Šetrajčič Dragoš, Mateja Krajc, Brigita Gregorič, Petra Škerl, Ksenija Strojnik, Gašper Klančar, Marta Banjac, and et al. 2022. "Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing" Cancers 14, no. 6: 1434. https://doi.org/10.3390/cancers14061434

Stegel, V., Blatnik, A., Škof, E., Dragoš, V. Š., Krajc, M., Gregorič, B., Škerl, P., Strojnik, K., Klančar, G., Banjac, M., Žgajnar, J., Ravnik, M., & Novaković, S. (2022). Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing. Cancers, 14(6), 1434. https://doi.org/10.3390/cancers14061434